Titre : Cellules THP-1

Cellules THP-1 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Observer Variation
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cellules THP-1 : Questions médicales les plus fréquentes", "headline": "Cellules THP-1 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cellules THP-1 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-26", "dateModified": "2025-03-21", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cellules THP-1" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Lignée cellulaire tumorale", "url": "https://questionsmedicales.fr/mesh/D045744", "about": { "@type": "MedicalCondition", "name": "Lignée cellulaire tumorale", "code": { "@type": "MedicalCode", "code": "D045744", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.251.860.180" } } }, "about": { "@type": "MedicalCondition", "name": "Cellules THP-1", "alternateName": "THP-1 Cells", "code": { "@type": "MedicalCode", "code": "D000074084", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Terumasa Ikeda", "url": "https://questionsmedicales.fr/author/Terumasa%20Ikeda", "affiliation": { "@type": "Organization", "name": "2 Institute for Molecular Virology, Minneapolis, MN 55455, USA." } }, { "@type": "Person", "name": "Michael A Carpenter", "url": "https://questionsmedicales.fr/author/Michael%20A%20Carpenter", "affiliation": { "@type": "Organization", "name": "3 Center for Genome Engineering, Minneapolis, MN 55455, USA." } }, { "@type": "Person", "name": "William L Brown", "url": "https://questionsmedicales.fr/author/William%20L%20Brown", "affiliation": { "@type": "Organization", "name": "4 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA." } }, { "@type": "Person", "name": "Reuben S Harris", "url": "https://questionsmedicales.fr/author/Reuben%20S%20Harris", "affiliation": { "@type": "Organization", "name": "3 Center for Genome Engineering, Minneapolis, MN 55455, USA." } }, { "@type": "Person", "name": "Valentina Galbiati", "url": "https://questionsmedicales.fr/author/Valentina%20Galbiati", "affiliation": { "@type": "Organization", "name": "Università Degli Studi di Milano, Laboratory of Toxicology, Dipartimento di Scienze Politiche ed Ambientali, Milan, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A Novel Method to Improve Inter-Clinician Variation in the Diagnosis of Retinopathy of Prematurity Using Machine Learning.", "datePublished": "2022-11-02", "url": "https://questionsmedicales.fr/article/36322485", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/02713683.2022.2139847" } }, { "@type": "ScholarlyArticle", "name": "Inter-observer variability of expert-derived morphologic risk predictors in aortic dissection.", "datePublished": "2022-08-27", "url": "https://questionsmedicales.fr/article/36029344", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00330-022-09056-z" } }, { "@type": "ScholarlyArticle", "name": "Inter-observer Variability of Clinical Activity Score: Assessments in Patients With Thyroid Eye Disease.", "datePublished": "2023-04-06", "url": "https://questionsmedicales.fr/article/37028695", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ajo.2023.03.027" } }, { "@type": "ScholarlyArticle", "name": "Evaluation of validity and reliability of video analysis and live observations to assess trauma team performance.", "datePublished": "2022-07-11", "url": "https://questionsmedicales.fr/article/35817942", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00068-022-02004-y" } }, { "@type": "ScholarlyArticle", "name": "Intra- and inter-observer agreement in distal radius fracture dislocation measurement of casting position.", "datePublished": "2023-07-21", "url": "https://questionsmedicales.fr/article/37493603", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2340/17453674.2023.13707" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Cellules", "item": "https://questionsmedicales.fr/mesh/D002477" }, { "@type": "ListItem", "position": 3, "name": "Cellules cultivées", "item": "https://questionsmedicales.fr/mesh/D002478" }, { "@type": "ListItem", "position": 4, "name": "Cellules cancéreuses en culture", "item": "https://questionsmedicales.fr/mesh/D014407" }, { "@type": "ListItem", "position": 5, "name": "Lignée cellulaire tumorale", "item": "https://questionsmedicales.fr/mesh/D045744" }, { "@type": "ListItem", "position": 6, "name": "Cellules THP-1", "item": "https://questionsmedicales.fr/mesh/D000074084" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cellules THP-1 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cellules THP-1", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cellules THP-1", "description": "Comment identifier les cellules THP-1 en laboratoire ?\nQuels tests sont utilisés pour caractériser les cellules THP-1 ?\nLes cellules THP-1 peuvent-elles être contaminées ?\nQuelle est la source des cellules THP-1 ?\nLes cellules THP-1 sont-elles sensibles à des médicaments ?", "url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Observer+Variation&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cellules THP-1", "description": "Quels sont les marqueurs d'activation des cellules THP-1 ?\nLes cellules THP-1 montrent-elles des signes d'inflammation ?\nComment les cellules THP-1 réagissent-elles aux pathogènes ?\nLes cellules THP-1 peuvent-elles se différencier ?\nQuels effets ont les cytokines sur les cellules THP-1 ?", "url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Observer+Variation&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cellules THP-1", "description": "Comment prévenir la contamination des cellules THP-1 ?\nQuelles conditions de culture sont idéales pour les cellules THP-1 ?\nLes cellules THP-1 nécessitent-elles des soins particuliers ?\nComment assurer la viabilité des cellules THP-1 ?\nLes cellules THP-1 peuvent-elles être cryogénisées ?", "url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Observer+Variation&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cellules THP-1", "description": "Comment les cellules THP-1 sont-elles utilisées en recherche ?\nPeut-on modifier génétiquement les cellules THP-1 ?\nQuels traitements sont testés sur les cellules THP-1 ?\nLes cellules THP-1 peuvent-elles être utilisées pour des tests de toxicité ?\nComment les cellules THP-1 aident-elles à comprendre les maladies ?", "url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Observer+Variation&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cellules THP-1", "description": "Quelles complications peuvent survenir lors de l'utilisation des cellules THP-1 ?\nLes cellules THP-1 peuvent-elles induire des réponses immunitaires indésirables ?\nQuels risques sont associés à la manipulation des cellules THP-1 ?\nLes cellules THP-1 peuvent-elles être affectées par des agents externes ?\nComment minimiser les complications lors des expériences avec THP-1 ?", "url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Observer+Variation&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cellules THP-1", "description": "Quels facteurs influencent la croissance des cellules THP-1 ?\nLes cellules THP-1 sont-elles sensibles à des agents environnementaux ?\nQuels traitements peuvent affecter les cellules THP-1 ?\nLes cellules THP-1 sont-elles affectées par le stress oxydatif ?\nQuels facteurs génétiques influencent les cellules THP-1 ?", "url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Observer+Variation&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier les cellules THP-1 en laboratoire ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les cellules THP-1 sont identifiées par leur morphologie et leur expression de marqueurs spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour caractériser les cellules THP-1 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme la cytométrie en flux et l'immunofluorescence sont utilisés." } }, { "@type": "Question", "name": "Les cellules THP-1 peuvent-elles être contaminées ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, comme toutes les lignées cellulaires, elles peuvent être contaminées par des bactéries ou des mycoplasmes." } }, { "@type": "Question", "name": "Quelle est la source des cellules THP-1 ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les cellules THP-1 proviennent de la moelle osseuse d'un patient atteint de leucémie." } }, { "@type": "Question", "name": "Les cellules THP-1 sont-elles sensibles à des médicaments ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent utilisées pour tester la sensibilité à divers agents pharmacologiques." } }, { "@type": "Question", "name": "Quels sont les marqueurs d'activation des cellules THP-1 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les marqueurs incluent CD14, CD11b et CD68, indiquant leur activation." } }, { "@type": "Question", "name": "Les cellules THP-1 montrent-elles des signes d'inflammation ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles produisent des cytokines pro-inflammatoires lorsqu'elles sont activées." } }, { "@type": "Question", "name": "Comment les cellules THP-1 réagissent-elles aux pathogènes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles phagocytent les pathogènes et sécrètent des médiateurs inflammatoires." } }, { "@type": "Question", "name": "Les cellules THP-1 peuvent-elles se différencier ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent se différencier en macrophages sous l'influence de certains facteurs." } }, { "@type": "Question", "name": "Quels effets ont les cytokines sur les cellules THP-1 ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les cytokines modulent leur activation et leur capacité à produire d'autres médiateurs." } }, { "@type": "Question", "name": "Comment prévenir la contamination des cellules THP-1 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des techniques aseptiques et vérifier régulièrement la pureté cellulaire." } }, { "@type": "Question", "name": "Quelles conditions de culture sont idéales pour les cellules THP-1 ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Elles nécessitent un milieu riche en nutriments et une température contrôlée." } }, { "@type": "Question", "name": "Les cellules THP-1 nécessitent-elles des soins particuliers ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles doivent être manipulées avec précaution pour éviter le stress cellulaire." } }, { "@type": "Question", "name": "Comment assurer la viabilité des cellules THP-1 ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir des conditions optimales de culture et éviter les cycles de congélation-décongélation." } }, { "@type": "Question", "name": "Les cellules THP-1 peuvent-elles être cryogénisées ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être cryogénisées pour une conservation à long terme." } }, { "@type": "Question", "name": "Comment les cellules THP-1 sont-elles utilisées en recherche ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont utilisées pour étudier les mécanismes immunitaires et tester des médicaments." } }, { "@type": "Question", "name": "Peut-on modifier génétiquement les cellules THP-1 ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des techniques comme CRISPR peuvent être utilisées pour modifier leur génome." } }, { "@type": "Question", "name": "Quels traitements sont testés sur les cellules THP-1 ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements anti-inflammatoires et anticancéreux sont souvent testés." } }, { "@type": "Question", "name": "Les cellules THP-1 peuvent-elles être utilisées pour des tests de toxicité ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent utilisées pour évaluer la toxicité des composés chimiques." } }, { "@type": "Question", "name": "Comment les cellules THP-1 aident-elles à comprendre les maladies ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Elles modélisent des maladies inflammatoires et infectieuses pour étudier les mécanismes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir lors de l'utilisation des cellules THP-1 ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des résultats biaisés peuvent survenir si les cellules sont contaminées ou mal caractérisées." } }, { "@type": "Question", "name": "Les cellules THP-1 peuvent-elles induire des réponses immunitaires indésirables ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent parfois produire des réponses immunitaires non spécifiques." } }, { "@type": "Question", "name": "Quels risques sont associés à la manipulation des cellules THP-1 ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Le risque principal est la contamination croisée avec d'autres lignées cellulaires." } }, { "@type": "Question", "name": "Les cellules THP-1 peuvent-elles être affectées par des agents externes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des agents comme les toxines ou les médicaments peuvent altérer leur fonction." } }, { "@type": "Question", "name": "Comment minimiser les complications lors des expériences avec THP-1 ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Suivre des protocoles stricts et effectuer des contrôles réguliers de qualité." } }, { "@type": "Question", "name": "Quels facteurs influencent la croissance des cellules THP-1 ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme la température, le pH et la composition du milieu influencent leur croissance." } }, { "@type": "Question", "name": "Les cellules THP-1 sont-elles sensibles à des agents environnementaux ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être affectées par des agents chimiques ou physiques dans leur environnement." } }, { "@type": "Question", "name": "Quels traitements peuvent affecter les cellules THP-1 ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements comme les cytokines ou les médicaments peuvent moduler leur activité." } }, { "@type": "Question", "name": "Les cellules THP-1 sont-elles affectées par le stress oxydatif ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress oxydatif peut altérer leur fonction et leur viabilité." } }, { "@type": "Question", "name": "Quels facteurs génétiques influencent les cellules THP-1 ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Des variations génétiques peuvent affecter leur réponse aux stimuli immunitaires." } } ] } ] }

Sources (10000 au total)

A Novel Method to Improve Inter-Clinician Variation in the Diagnosis of Retinopathy of Prematurity Using Machine Learning.

Inter-clinician variation could cause uncertainty in disease management. This is reported to be high in Retinopathy of Prematurity (ROP), a potentially blinding retinal disease affecting premature inf... An anonymized survey of ROP images was administered to the expert(s) and the trainee(s) using a study-designed user interface. The results were analyzed for repeatability as well as to identify the le... Correlation and disagreement between the expert and the trainees were visualized using the Dipstick™ diagram. Intra-clinician repeatability and reclassification statistics were assessed for all. The r... This novel, automated algorithm quantifies the differences using machine learning techniques. This will help audit the training process by objectively measuring differences between experts and trainee... Training for image-based ROP diagnosis can be more objectively performed using this novel, machine learning-based automated image analyzer and classifier....

Inter-observer variability of expert-derived morphologic risk predictors in aortic dissection.

Establishing the reproducibility of expert-derived measurements on CTA exams of aortic dissection is clinically important and paramount for ground-truth determination for machine learning.... Four independent observers retrospectively evaluated CTA exams of 72 patients with uncomplicated Stanford type B aortic dissection and assessed the reproducibility of a recently proposed combination o... Pre-training ICCs of the four morphologic features ranged from 0.04 (-0.05 to 0.13) to 0.68 (0.49-0.81) between observer 1 and observers 2-4 and from 0.50 (0.32-0.69) to 0.89 (0.78-0.95) between obser... Manual morphologic feature measurements on CTA images can be optimized resulting in improved inter-observer reliability. This is essential for robust ground-truth determination for machine learning mo... • Clinical fashion manual measurements of aortic CTA imaging features showed poor inter-observer reproducibility. • A standardized workflow with standardized training resulted in substantial improveme...

Inter-observer Variability of Clinical Activity Score: Assessments in Patients With Thyroid Eye Disease.

Thyroid eye disease (TED) can be difficult to manage. The range of available treatments is expanding rapidly; however, cost is a concern and some patients do not respond. The Clinical Activity Score (... Prospective reliability analysis.... Nine patients with a spectrum of clinical features of TED were assessed by 6 experienced observers on the same day. Agreement among the observers was analyzed using the Krippendorff alpha.... The Krippendorff alpha for the total CAS was 0.532 (95% CI = 0.199-0.665), whereas alpha values for the individual components of the CAS varied between 0.171 (CI = 0.000-0.334) for lid redness and 0.6... This study has shown unreliable inter-observer variability in total CAS and most individual CAS components, thus highlighting the need for improving the performance of the CAS or seeking other methods...

Evaluation of validity and reliability of video analysis and live observations to assess trauma team performance.

A trauma resuscitation is dynamic and complex process in which failures could lead to serious adverse events. In several trauma centers, evaluation of trauma resuscitation is part of a hospital's qual... In this prospective observational study, validity was assessed by comparing the observed adherence to 28 advanced trauma life support (ATLS) guideline related tasks by video analysis to life observati... Eleven simulated and thirteen real-life resuscitations were assessed. Overall, the percentage of observed ATLS related tasks performed during simulated resuscitations was 10.4% (P < 0.001) higher when... Video analysis of trauma resuscitations may be more valid and reliable compared to evaluation by live observers. These outcomes may guide the debate to justify video review instead of live observation...

Intra- and inter-observer agreement in distal radius fracture dislocation measurement of casting position.

Most displaced distal radius fractures (DRF) are treated nonoperatively, with reduction and immobilization in a cast. Studies assessing intra- or inter-observer agreement on radiologic measurements of... Our study is based on the Kuopio Osteoporosis Risk Factor and Prevention (OSTPRE) study. All detected DRFs during the OSTPRE follow-up were retrieved and based on sample size calculations 50 fractures... For radial inclination, radial shortening, and dorsal/volar tilt, intra- and inter-observer correlations were high (CCC > 0.76). In addition, measurements of wrist angle in a splint had high correlati... Intra- and inter-observer repeatability of casting position of radial inclination, radial shortening, and dorsal/volar tilt were high whereas intra-articular gap and step had poor correlations....

Inter-observer agreement in grading severity of diabetic retinopathy in wide-field fundus photographs.

To examine the inter-observer agreement between two retina specialists in grading diabetic retinopathy (DR) severity in ultra-wide-field fundus photographs.... Two hundred and seventy patients with diabetes, who visited the vitreoretinal specialty at a tertiary eye care hospital, with or without DR underwent comprehensive ophthalmic examination, dilated reti... The two graders showed agreement in 229/270 images (84.8%) and disagreement in 41/270 images (15.2%). The unweighted kappa for agreement between graders was k = 0.715, SE = 0.037 and the weighted kapp... The impact of disagreement noted between observers in grading DR on UWF fundus photographs should be considered when utilizing UWF system in clinical studies....

Comparison of supervised-learning approaches for designing a channelized observer for image quality assessment in CT.

The current paradigm for evaluating computed tomography (CT) system performance relies on a task-based approach. As the Hotelling observer (HO) provides an upper bound of observer performances in spec... Here we investigated the efficiency of a supervised ML-algorithm used to design a CO for predicting the performance of unconstrained HO. The ML-algorithm was applied either (1) in the estimator for di... A channelized support vector machine (CSVM) was employed and compared against the CHO in terms of ability to predict HO performances. Both the CSVM and the CHO were estimated with channels derived fro... The CSVM outperformed the CHO for all types of channels and regularization strategies. Furthermore, even though both COs generalized well to images reconstructed with the same regularization strategy ... These results argue for introducing the supervised-learning paradigm in the detector function rather than in the operator of the channels when designing a CO to provide an accurate estimate of HO perf...

Impact of metal artifact reduction algorithm on gross tumor volume delineation in tonsillar cancer: reducing the interobserver variation.

Patients with tonsillar cancer (TC) often have dental fillings that can significantly degrade the quality of computed tomography (CT) simulator images due to metal artifacts. We evaluated whether the ... Eighteen patients with TC with dental fillings were enrolled in this study. Contrast-enhanced CT simulator images were reconstructed using the conventional (CT... GTV... The use of the MAR algorithm led to the delineation of smaller GTVs and reduced interobserver variations in delineating GTV of the primary tumors in patients with TC....